| Dr Tracy C Sepich, OD | |
|
100 Oakwood Avenue, Ste 300, State College, PA 16803 | |
| (814) 272-0262 | |
| (814) 272-1501 |
| Full Name | Dr Tracy C Sepich |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 33 Years |
| Location | 100 Oakwood Avenue, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407826969 | NPI | - | NPPES |
| 0014195820005 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG000589 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Restore Eye Care, P.c. | 7719909829 | 2 |
News Archive
The U.S. Department of Defense recently awarded more than $18 million in funding to a unit of Lonza Group, Ltd. for the development and commercialization of the therapeutic candidate, PermaDerm™ for the treatment of severe burns among U.S. troops and civilians. The funding was announced at a conference celebrating advancements in regenerative medicine on November 9th in Walkersville, MD.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).
Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at The University of Texas MD Anderson Cancer Center have discovered a particularly high prevalence of hereditary cancers among those diagnosed with the disease before the age of 35. They suggest that these patients should undergo genetic counseling to determine if their families may be at an elevated risk.
Although growing numbers of people check their symptoms with "Dr. Google" or seek other medical advice online, many still lack the access and skills to take advantage of the Web's wealth of health information.
› Verified 3 days ago
| Provider Name | Restore Eye Care, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821078569 PECOS PAC ID: 7719909829 Enrollment ID: O20060103000399 |
News Archive
The U.S. Department of Defense recently awarded more than $18 million in funding to a unit of Lonza Group, Ltd. for the development and commercialization of the therapeutic candidate, PermaDerm™ for the treatment of severe burns among U.S. troops and civilians. The funding was announced at a conference celebrating advancements in regenerative medicine on November 9th in Walkersville, MD.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).
Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at The University of Texas MD Anderson Cancer Center have discovered a particularly high prevalence of hereditary cancers among those diagnosed with the disease before the age of 35. They suggest that these patients should undergo genetic counseling to determine if their families may be at an elevated risk.
Although growing numbers of people check their symptoms with "Dr. Google" or seek other medical advice online, many still lack the access and skills to take advantage of the Web's wealth of health information.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tracy C Sepich, OD 100 Oakwood Avenue, Ste 300, State College, PA 16803 Ph: (814) 272-0262 | Dr Tracy C Sepich, OD 100 Oakwood Avenue, Ste 300, State College, PA 16803 Ph: (814) 272-0262 |
News Archive
The U.S. Department of Defense recently awarded more than $18 million in funding to a unit of Lonza Group, Ltd. for the development and commercialization of the therapeutic candidate, PermaDerm™ for the treatment of severe burns among U.S. troops and civilians. The funding was announced at a conference celebrating advancements in regenerative medicine on November 9th in Walkersville, MD.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).
Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at The University of Texas MD Anderson Cancer Center have discovered a particularly high prevalence of hereditary cancers among those diagnosed with the disease before the age of 35. They suggest that these patients should undergo genetic counseling to determine if their families may be at an elevated risk.
Although growing numbers of people check their symptoms with "Dr. Google" or seek other medical advice online, many still lack the access and skills to take advantage of the Web's wealth of health information.
› Verified 3 days ago
Michael J Talone, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 428 Windmere Dr, Suite 100, State College, PA 16801 Phone: 814-234-2015 Fax: 814-234-2015 | |
Brian Matthew Randecker, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2901 E College Ave, State College, PA 16801 Phone: 814-347-9604 | |
Dr. Marshall L. Goldstein, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 201 E Beaver Ave, State College, PA 16801 Phone: 814-238-2862 Fax: 814-234-2201 | |
Michael J Cymbor, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 428 Windmere Dr, Ste 100, State College, PA 16801 Phone: 814-234-2015 Fax: 814-238-5300 | |
Spectacles F.y.eye Optometrist Medicare: Medicare Enrolled Practice Location: 138 W College Ave, State College, PA 16801 Phone: 814-234-7788 Fax: 814-234-1105 | |
Dr. Dustin Edward Brown, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 428 Windmere Dr, State College, PA 16801 Phone: 814-234-2015 Fax: 814-238-5300 | |
Dr. Andrea Nicole Russell, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 428 Windmere Dr, Suite 100, State College, PA 16801 Phone: 814-234-2015 Fax: 814-238-5300 |